DR. JULIAN LIEB, MD
Psychiatric at Rimmon Rd, New Haven, CT
License number
Connecticut CT16254
Category
Psychiatric
Type
Psychiatry
Address
Address
22 Rimmon Rd, New Haven, CT 06525
Phone
(203) 397-1226
(203) 397-1246 (Fax)
(203) 397-1246 (Fax)
Personal information
See more information about JULIAN LIEB at radaris.comName
Address
Phone
138 Drum Hill Rd, Wilton, CT 06897
164 Alps Rd, Branford, CT 06405
22 Rimmon Rd, Woodbridge, CT 06525
41 Village Ln, Bethany, CT 06524
461 Whalley Ave, New Haven, CT 06511
Organization information
See more information about JULIAN LIEB at bizstanding.comJULIAN LIEB, M.D., PC
22 Rimmon Rd, Woodbridge, CT
Registration:
Oct 7, 1980
State ID:
0110165
Business type:
Stock
PRESIDENT:
Julian Lieb (PRESIDENT), 22 Rimmon Rd, Woodbridge, CT 06525 (Mailing)
Professional information
Dr. Julian Lieb, Woodbridge CT - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Psychiatry)
Address:
22 Rimmon Rd, Woodbridge 06525
(203) 397-1246 (Fax)
(203) 397-1246 (Fax)
Certifications:
Psychiatry, 1974
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of The Witwatersrand/Faculty of Health Sciences
Queen Victoria Hosp
Yale
University of The Witwatersrand/Faculty of Health Sciences
Queen Victoria Hosp
Yale
Treatment Of Disorders Of Inflammation And Immunity And Disorders Associated With Smooth Muscle Spasm And Compositions Therefor
US Patent:
4386072, May 31, 1983
Filed:
Feb 3, 1982
Appl. No.:
6/345214
Inventors:
David F. Horrobin - Nuns' Island, Montreal, CA
Julian Lieb - Bethany CT
Julian Lieb - Bethany CT
International Classification:
A61K 3300, A61K 3312, A61K 3120
US Classification:
424127
Abstract:
A method for the treatment or prophylaxis of disorders of inflammation and immunity and disorders associated with smooth muscle spasm, by administering dihomo-. gamma. -linolenic acid or a bioprecursor thereof conjointly with a physiologically acceptable lithium salt. Vitamin E and related tocopherols may optionally be also administered.
Treatment Of Auto-Immune And Inflammatory Diseases
US Patent:
4409243, Oct 11, 1983
Filed:
Nov 9, 1981
Appl. No.:
6/319651
Inventors:
Julian Lieb - Bethany CT
International Classification:
A61K 3115, A61K 3142, A61K 3144, A61K 31135
US Classification:
424330
Abstract:
A method for the treatment of inflammatory disorders and disorders of immunity, which disorders are characterized by excessive prostaglandin E2 biosynthesis, which method comprises administering an effective amount of a monoamine oxidase inhibitor.
Topical Pharmaceutical Compositions
US Patent:
5145686, Sep 8, 1992
Filed:
Jan 8, 1992
Appl. No.:
7/818501
Inventors:
David F. Horrobin - Montreal, CA
Julian Lieb - Bethany CT
Julian Lieb - Bethany CT
Assignee:
Efamol Limited - London
International Classification:
A61K 3314, A61K 3304, A61K 3300, A61K 3161
US Classification:
424677
Abstract:
Topical pharmaceutical compositions for the treatment of lesions of the skin or mucous membranes containing a physiologically acceptable lithium salt together with at least one substance selected from substances capable of selectively increasing the in vivo level of E-series prostaglandins, substances capable of inhibiting cyclooxygenase enzyme, substances capable of inhibiting the formation of lipoxygenase products, and lysine.
Treatment Of Auto-Immune And Inflammatory Diseases
US Patent:
4490385, Dec 25, 1984
Filed:
Oct 5, 1983
Appl. No.:
6/539306
Inventors:
Julian Lieb - Bethany CT
International Classification:
A61K 3142
US Classification:
424272
Abstract:
A method for the treatment of inflammatory disorders and disorders of immunity, which disorders are characterized by excessive prostaglandin E2 biosynthesis, which method comprises administering an effective amount of a monoamine oxidase inhibitor.
Manic-Depressive Illnesses
US Patent:
4328243, May 4, 1982
Filed:
Apr 7, 1981
Appl. No.:
6/251901
Inventors:
David F. Horrobin - Montreal, CA
Julian Lieb - Bethany CT
Julian Lieb - Bethany CT
International Classification:
A61U 3120, A61U 31265
US Classification:
424301
Abstract:
A method for the treatment and/or prophylaxis of the side-effects of lithium treatment in a subject suffering from manic-depressive psychosis, which method comprises administering to the subject an effective amount therefor of dihomogamma-linolenic acid and/or a biosynthetic precursor thereof.